IVZ

Invesco Ltd

Add to Watchlist

Advanced Chart

20.450

-0.27(-1.303%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

20.840

Open

20.750

VWAP

20.50

Vol

6.82M

Mkt Cap

9.12B

Low

20.410

Amount

139.85M

EV/EBITDA(TTM)

18.93

Total Shares

449.83M

20.79B

EV/OCF(TTM)

17.06

P/S(TTM)

2.29

Invesco Ltd. is an independent investment management firm. It serves the retail and institutional markets within the investment management industry in the Americas, Europe, Middle East, and Africa and Asia-Pacific in 120 countries. It offers a range of investment strategies across asset classes, investment styles, and geographies. Its asset classes include equity, fixed income, balanced, alternatives and money market. Its retail assets under management include exchange-traded funds, separately managed accounts, individual savings accounts, investment companies with variable capital, investment trusts, open-end mutual funds, unit investment trusts, and variable insurance funds. Its institutional assets include institutional separate accounts, private funds, open-end mutual funds, and collective trust funds. Its client base includes public and private entities, unions, non-profit organizations, endowments, foundations, financial institutions, and sovereign wealth funds.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

1.19B

+7.61%

0.518

+17.63%

1.21B

+4.34%

0.520

-0.09%

1.16B

+5.32%

0.472

+7.17%

Estimates Revision

The market is revising Upward the revenue expectations for Invesco Ltd. (IVZ) for FY2025, with the revenue forecasts being adjusted by 3.98% over the past three months. During the same period, the stock price has changed by 31.17%.

Revenue Estimates for FY2025

Revise Upward

+3.98%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+7.6%

In Past 3 Month

Stock Price

Go Up

+31.17%

In Past 3 Month

12 Analyst Rating

2.79% Upside

Wall Street analysts forecast IVZ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IVZ is 21.02 USD with a low forecast of 16.75 USD and a high forecast of 29.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

10 Hold

0 Sell

Hold

2.79% Upside

Current: 20.450

Low

16.75

Averages

21.02

High

29.00

2.79% Upside

Current: 20.450

Low

16.75

Averages

21.02

High

29.00

Barclays

Equal Weight

maintain

$17 -> $22

2025-07-23

Reason

Barclays

Price Target

$17 -> $22

2025-07-23

maintain

Equal Weight

Reason

Barclays raised the firm's price target on Invesco to $22 from $17 and keeps an Equal Weight rating on the shares. The company's flows were among the best in the group in Q2, the analyst tells investors in a research note.

Argus

Buy

maintain

$17 -> $25

2025-07-23

Reason

Argus

Price Target

$17 -> $25

2025-07-23

maintain

Buy

Reason

Argus raised the firm's price target on Invesco to $25 from $17 and keeps a Buy rating on the shares following the Q2 report. The firm says the company's QQQ conversion to exchanged traded fund status positions it for improved profitability.

TD Cowen

Hold

Buy

upgrade

$25

2025-07-21

Reason

TD Cowen

Price Target

$25

2025-07-21

upgrade

Hold

Buy

Reason

TD Cowen last night upgraded Invesco to Buy from Hold with a price target of $25, up from $17.50. The company's registration documents requesting to migrate its QQQ exchange traded fund from a unit investment trust to an open-end fund structure is a "game changing event," the analyst tells investors in a research note. TD believes the move is reflective of earnings accretion and sees room for additional multiple expansion for the shares as investors think through implications.

TD Cowen

Hold

Buy

upgrade

$25

2025-07-20

Reason

TD Cowen

Price Target

$25

2025-07-20

upgrade

Hold

Buy

Reason

TD Cowen upgraded Invesco to Buy from Hold with a price target of $25, up from $17.50.

Barclays

Equal Weight

maintain

$15 -> $17

2025-07-16

Reason

Barclays

Price Target

$15 -> $17

2025-07-16

maintain

Equal Weight

Reason

Barclays raised the firm's price target on Invesco to $17 from $15 and keeps an Equal Weight rating on the shares as part of a Q2 preview for the asset managers. The firm updated asset manager models to reflect full quarterly flow and asset under management metrics. Assets rose due to market appreciation in Q2, but though flow profiles remained mixed across the sector, the analyst tells investors in a research note.

Wells Fargo

Michael Brown

Underweight -> Equal Weight

upgrade

$18

2025-07-11

Reason

Wells Fargo

Michael Brown

Price Target

$18

2025-07-11

upgrade

Underweight -> Equal Weight

Reason

Wells Fargo analyst Michael Brown upgraded Invesco to Equal Weight from Underweight with a price target of $18, up from $14.50.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Invesco Ltd (IVZ.N) is 10.02, compared to its 5-year average forward P/E of 9.30. For a more detailed relative valuation and DCF analysis to assess Invesco Ltd 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair

5Y Average PE

9.30

Current PE

10.02

Overvalued PE

11.12

Undervalued PE

7.47

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

7.61

Current EV/EBITDA

7.99

Overvalued EV/EBITDA

8.78

Undervalued EV/EBITDA

6.43

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

1.76

Current PS

1.93

Overvalued PS

2.06

Undervalued PS

1.46